A recent study demonstrated that IGF2BP2 promoted the degradation of the RNA transcripts of the ATP6V1A gene, thereby impairing lysosomal function and resulting in a unique secretome that greatly enhances breast cancer cell invasiveness 20. Here, ATP6V1A is linked to breast carcinoma.